Compare Cytokinetics Inc (CYTK) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Prudential Financial Inc — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Prudential Financial Inc trades at $122.99 (market cap $42.20B). The key difference: Prudential Financial Inc is far larger — about 4× Cytokinetics Inc's market cap, and Prudential Financial Inc pays a 4.58% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | PRU | |
|---|---|---|
Market Cap | $10.63B | $42.20B |
Sector | Technology | Financials |
52-Week High | $87.26 | $123.93 |
52-Week Low | $34.31 | $92.00 |
Enterprise Value | $10.74B | $70.98B |
Dividend Yield | — | 4.58% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
